We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

With a market cap of $258 billion, Merck & Co., Inc. (MRK) is a global healthcare company, operating in the pharmaceutical and animal health sectors. Based in Rahway, New Jersey, Merck develops ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $103.98 which represents a decrease of $-1.90 or -1.79% from the prior close of $105.88. The stock opened at $106.49 and touched ...

Merck (MRK) will be in focus as company beats revenue forecasts despite in line earnings amid strong Keytruda sales in Q3 ...

Investor focus is likely to be on the sales of Merck's blockbuster oncology medicine, Keytruda, when the company reports ...

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

Thank you, Shirley, and good morning, everyone. Welcome to Merck's third-quarter 2024 conference call. Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline ...

Merck's Keytruda now approved by European Commission for new gynecologic cancer indications, expanding its reach in the EU.

Merck (MRK) and Moderna (MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 randomized clinical trial evaluating V940, an ...